Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 5NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma, Large B-Cell, Diffuse 40Lymphoma 37Lymphoma, Follicular 33Leukemia, Lymphocytic, Chronic, B-Cell 32Lymphoma, Mantle-Cell 23Lymphoma, Non-Hodgkin 22Lymphoma, B-Cell, Marginal Zone 19Burkitt Lymphoma 19Waldenstrom Macroglobulinemia 14Leukemia 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Large-Cell, Immunoblastic 10Multiple Myeloma 6Lymphoma, B-Cell 6Leukemia, Hairy Cell 6Hodgkin Disease 6Leukemia, Prolymphocytic 5Myelodysplastic Syndromes 4Lymphoma, AIDS-Related 4Dendritic Cell Sarcoma, Interdigitating 4Plasmablastic Lymphoma 3Lymphoma, Primary Effusion 3Lymphoma, Large-Cell, Anaplastic 3HIV Infections 3Epstein-Barr Virus Infections 3Neoplasms, Plasma Cell 2Neoplasms 2Neoplasm, Residual 2Myeloproliferative Disorders 2Lymphoproliferative Disorders 2

Interventions

Vincristine 3Prednisone 3Doxorubicin 3Cyclophosphamide 3Rituximab 2Etoposide 2vandetanib 1motesanib diphosphate 1liposomal doxorubicin 1denileukin diftitox 1Zidovudine 1Valganciclovir 1Tomography, X-Ray Computed 1Sirolimus 1Nivolumab 1Interferons 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Echocardiography 1EPOCH protocol 1Caves 1Brentuximab Vedotin 1Bortezomib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Lymphoproliferative Disorders × Rituximab × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
94 enrolled 20 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡